The effect of alcoholism on Parkinson's disease
Sandyk, R.
South African Medical Journal 63(18): 678
1983
ISSN/ISBN: 0256-9574 PMID: 6845075 Document Number: 219260
Document emailed within 1 workday
Related Documents
Vernay, D.; Eschalier, A.; Durif, F.; Aumaitre, O.; Rigal, B.; Ben Sadoun, A.; Fialip, J.; Marty, H.; Philip, E.; Bougerolle, A.M. 1989: Salsolinol, an endogenous molecule. Possible implications in alcoholism, Parkinson's disease and pain L'Encephale 15(6): 511-516Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Dixit, S.N.; Behari, M.; Ahuja, G.K. 1999: Effect of selegiline on cognitive functions in Parkinson's disease Journal of the Association of Physicians of India 47(8): 784-786
Xu, D.L.; Yu, W.C.; Pan, G.B.; Chen, S.D. 1987: Mechanism of action of L-leucyl-glycinamide and its effect on Parkinson's disease Advances in Neurology 45: 587-590
Karimova, M.K.; Vartanian, K.Z.; Petelin, L.S.; Kubatiev, A.A. 1994: Effect of veroshpiron on hormone level in patients with Parkinson's disease Klinicheskaia Meditsina 72(4): 36-39
Prabhakar, S.; Syal, P.; Srivastava, T. 2000: P300 in newly diagnosed non-dementing Parkinson's disease: effect of dopaminergic drugs Neurology India 48(3): 239-242
Hirsch, E.C. 2000: Nigrostriatal system plasticity in Parkinson's disease: effect of dopaminergic denervation and treatment Annals of Neurology 47(4 Suppl 1): S115
Cernibori 1970: Electrophysiological effect of Levodopa on the phenomena of spinal inhibition and facilitation in Parkinson's disease Rivista di Neurologia 40(5): 303-309
Potrebić, A.; Dragasević, N.; Svetel, M.; Kostić, V.S. 2001: Effect of slow repetitive transcranial magnetic stimulation on depression in patients with Parkinson disease Srpski Arhiv Za Celokupno Lekarstvo 129(1-2): 1-4
Jost, W.H.; Schimrigk, K. 1994: The effect of cisapride on delayed colonic transit time in patients with idiopathic Parkinson's disease Wiener Klinische Wochenschrift 106(21): 673-676
Kida, E.; Renkawek, K. 1986: Effect of serum and cerebrospinal fluid of patients with Parkinson's disease on the ultrastructural properties of rat striatum in vitro Neuropatologia Polska 24(1): 17-27
Zheng, L.; Wang, H.; Ba, Y.-Y.; Liu, H.-L.; Wang, M.; Guo, W.-W.; Wu, X.; Yang, H. 2014: Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease Zhongguo Zhong Yao Za Zhi 39(9): 1660-1665
Fiszer, U. 1989: Study of the immunologic status of persons with Parkinson disease with special reference to the effect of levodopa treatment. Preliminary report Neurologia i Neurochirurgia Polska 23(1): 7-11
Aaltonen, H.; Kilkku, O.; Heinonen, E.; Mäki-Ikola, O. 1998: Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortality Bmj 317(7172): 1586-1587
Counsell, C. 1998: Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Formal systematic review of data on patients in all relevant trials is required Bmj 317(7172): 1586
Mastaglia, F.L.; Masters, C.L.; Beyreuther, K.; Kakulas, B.A. 1989: Deposition of Alzheimer's disease amyloid (A4) protein in the cerebral cortex in Parkinson's disease Progress in Clinical and Biological Research 317: 475-484
Braak, H.; Braak, E.; Yilmazer, D.; de Vos, R.A.; Jansen, E.N.; Bohl, J. 1996: New aspects of pathology in Parkinson's disease with concomitant incipient Alzheimer's disease Journal of Neural Transmission. Supplementum 48: 1-6